We are Science Accelerated
We are KCAS Bio, your full-service, global bioanalytical CRO partner with the expertise, capacity and flexibility sponsors require.
Bioanalytical CRO service excellence
We take a consultative approach to our discovery and bioanalytical services, giving our clients' confidence their needs are understood, their objectives will be met, and our promises kept. We consistently benchmark, evaluate and optimize our operations so we can help scientific innovators and investors.
We have supported more than 300+ FDA approved drugs on the market, developed 5,000+ proprietary and non-proprietary assays to date, and undergone 18 FDA audits with no major findings.
Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve sponsors globally with bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management.
Spectral Flow Cytometry on a Global Scale
KCAS Bio is the only bioanalytical laboratory with globally harmonized Cytek spectral flow cytometers, with sites in the US, EU and Australia.
Global biomarker and bioanalytical CRO solutions
KCAS Bio is an established bioanalytical CRO with over 40 years' experience. We are very mindful of the human and financial impact of drug development delays. Through our unique approach to capacity planning, we prepare the right expertise with the right capacity and equipment so that we can keep development moving smoothly. Our clients consider us a reliable partner because we strive to minimize downtime, avoid delays, and keep lead times as short as possible.
Find exactly what you’re looking for
Search for specific services, platforms, instrumentation, or scientific insights.
KCAS Bio scientific insights
Blogs
Understanding the intricate relationship between drugs and the human body is crucial for effective medical treatments. Two fundamental concepts in pharmacology, pharmacokinetics and pharmacodynamics, play pivotal roles in this understanding. This blog post will delve into these concepts, exploring their differences and significance in drug development and clinical practice. Introduction…
Blogs
Cell-based immunotherapies like Chimeric Antigen Receptor (CAR)-T cell therapy have been transforming the treatment of hematologic malignancies for more than a decade. Several groundbreaking studies (1) have led to a growing interest in applying these cell-based therapies to other T and B cell-mediated diseases. One emerging application of CARs is…
Podcasts
Episode 17 of The Conversational Flow podcast, hosted by Brian Wile and Adam Cotty, dives into the evolving landscape of flow cytometry networking and regulatory guidance, where they analyze recent FDA biomarker validation guidance, comparing it to existing industry standards like CLSI H62. Our hosts explore the challenges of harmonizing flow cytometry…
Advancing great people and great science
We make nurturing new talent a strategic priority, so that teams are dynamic and constantly improving. We provide a supportive environment for continuous learning and training where you can become your best.
What our clients say
We consistently earn our clients’ trust based on our reputation for transparency, delivering error-free data and keeping our promises.
Tell us how we can help with your project
We've earned our reputation for delivering reliable, error-free data. We understand the importance of speed, flexibility, and consistency and only make promises we can keep.